Jasti BR - Search Results

1

Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.

Boinpally RR, Polin L, Zhou SL, Jasti BR, Wiegand RA, White K, Kushner J, Horwitz JP, Corbett TH, Parchment RE. Boinpally RR, et al. Among authors: jasti br. Cancer Chemother Pharmacol. 2003 Jul;52(1):25-33. doi: 10.1007/s00280-003-0621-0. Epub 2003 May 9. Cancer Chemother Pharmacol. 2003. PMID: 12739061

2

Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30.

Poondru S, Parchment RE, Purohit V, LoRusso P, Horwitz JP, Hazeldine ST, Polin L, Corbett T, Jasti BR. Poondru S, et al. Among authors: jasti br. Invest New Drugs. 2002 Feb;20(1):23-33. doi: 10.1023/a:1014457510073. Invest New Drugs. 2002. PMID: 12003192

3

Taxanes: an overview of the pharmacokinetics and pharmacodynamics.

Vaishampayan U, Parchment RE, Jasti BR, Hussain M. Vaishampayan U, et al. Among authors: jasti br. Urology. 1999 Dec;54(6A Suppl):22-9. doi: 10.1016/s0090-4295(99)00451-3. Urology. 1999. PMID: 10606281 Review.

4

High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma.

Poondru S, Zhou S, Rake J, Shackleton G, Corbett TH, Parchment RE, Jasti BR. Poondru S, et al. Among authors: jasti br. J Chromatogr B Biomed Sci Appl. 2001 Aug 5;759(1):175-8. doi: 10.1016/s0378-4347(01)00217-1. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11499623

5

Iontophoresis of lecithin vesicles of cyclosporin A.

Boinpally RR, Zhou SL, Devraj G, Anne PK, Poondru S, Jasti BR. Boinpally RR, et al. Among authors: jasti br. Int J Pharm. 2004 Apr 15;274(1-2):185-90. doi: 10.1016/j.ijpharm.2004.01.016. Int J Pharm. 2004. PMID: 15072794

6

Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects.

Bolla S, Boinpally RR, Poondru S, Devaraj R, Jasti BR. Bolla S, et al. Among authors: jasti br. J Clin Pharmacol. 2002 Mar;42(3):327-31. doi: 10.1177/00912700222011247. J Clin Pharmacol. 2002. PMID: 11865970

7

Lecithin vesicles for topical delivery of diclofenac.

Boinpally RR, Zhou SL, Poondru S, Devraj G, Jasti BR. Boinpally RR, et al. Among authors: jasti br. Eur J Pharm Biopharm. 2003 Nov;56(3):389-92. doi: 10.1016/s0939-6411(03)00143-7. Eur J Pharm Biopharm. 2003. PMID: 14602181

8

Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU).

LoRusso PM, Prakash S, Wozniak A, Flaherty L, Zalupski M, Shields A, Sands H, Parchment R, Jasti B. LoRusso PM, et al. Invest New Drugs. 2002 Feb;20(1):63-71. doi: 10.1023/a:1014430216434. Invest New Drugs. 2002. PMID: 12003195 Free article. Clinical Trial.

9

Novel in vitro model barriers for evaluation of the permeability of antitumor compounds, thioxanthones.

Marasanapalle V, Li X, Polin L, Jasti BR. Marasanapalle V, et al. Among authors: jasti br. Invest New Drugs. 2006 Mar;24(2):111-6. doi: 10.1007/s10637-006-5933-6. Invest New Drugs. 2006. PMID: 16502352

10

A novel method for determination of drug solubility in polymeric matrices.

Jasti BR, Berner B, Zhou SL, Li X. Jasti BR, et al. J Pharm Sci. 2004 Aug;93(8):2135-41. doi: 10.1002/jps.20122. J Pharm Sci. 2004. PMID: 15236460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters